This Solicitation opportunity from Department Of Defense was posted on July 30, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

DEXTROSE INJECTION

Closed

SPE2DP-26-T-4393Federal

Submission Closed08/05/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

Supply of Bupivacaine Hydrochloride InjectionThis subcontract involves the supply of pharmaceutical-grade Bupivacaine Hydrochloride Injection, USP, 0.5%, 50 ML (NSN: 6505001387347) to prime contractors supporting Department of Defense DLA Troop Support medical supply contracts. The agreement requires the delivery of 2,000 units within a strict five-day window, ensuring all products meet USP standards and possess a minimum shelf-life of 24 months. To maintain product integrity, the supplier must utilize climate-controlled logistics to keep the injections within a temperature range of 20 to 25 degrees Celsius. This procurement is managed under NAICS code 325412 through the Medical Supply Chain Pharm FSA.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Simethicone Tablets (USP) SupplyThis subcontract involves the supply of Simethicone Tablets, USP, 80 MG, Chewable, for prime contractors delivering to the Department of Defense Medical Supply Chain Pharm FSA. The contractor is responsible for manufacturing or sourcing the tablets according to USP standards, ensuring they are produced in FDA-approved facilities. The product must be delivered in unit dose 100-count blister packs with a minimum shelf life of 36 months and must adhere to Medical Marking Standard No. 1. The contract is categorized under NAICS code 325412 and is associated with a performance location in Washington. Interested parties should note the response deadline of November 4, 2026, for this procurement effort.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of Casualty Triage Tags (NSN 6515015871700)

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of Loratadine Tablets 10 MGThis subcontract involves the supply of pharmaceutical-grade Loratadine 10 MG tablets, identified by NSN 6505-01-524-9179, to prime contractors supporting the Department of Defense Medical Supply Chain. The tablets must be packaged in bottles of 500 units and maintain a non-extendable shelf life of 36 months. To ensure product integrity, the contract mandates strict climate-controlled storage and transport conditions, requiring temperatures to be held between 20 to 25 degrees Celsius and protection from moisture. The performance of this contract is centered at Camp Pendleton, California. Interested parties must adhere to the timeline associated with the solicitation, which was posted on October 29, 2026, with a response deadline of November 4, 2026. The procurement falls under NAICS code 325412 and is managed by the Medical Supply Chain Pharm FSA.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Hydrogen Peroxide Topical SolutionThis subcontract involves the supply of 50 bottles of 3% stabilized hydrogen peroxide topical solution, with each bottle containing 473ml, for prime contractors supporting the Department of Defense Medical Supply Chain Pharm FSA. The products must strictly adhere to Medical Marking Standard No. 1 and be packaged according to MIL-STD-2073-1E and MPPWN00001. Delivery is required FOB Destination to Washington. Due to the nature of the product, the contractor must ensure full compliance with hazardous materials regulations, including 49 CFR, 29 CFR, ICAO, and IMDG standards. The opportunity is categorized under NAICS code 325412, with a response deadline set for November 4, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supplier of Sterile Surgical Lubricant (NSN 6505016265774)

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

ARTIFICIAL TEARS SOLUT

Solicitation # SPE2DP-27-T-0204

Solicitation SPE2DP-27-T-0204 is a small business set-aside issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of 40 bottles of 1.4% artificial tears solution (NSN 6505009617486), each with a 15 ML capacity. The contract requires a non-extendable shelf life of 36 months and specifies delivery to the USS NITZE DDG 94. Delivery is required within 20 days after receipt of order, with an original required delivery date of October 28, 2026. The terms are FOB Destination, and both inspection and acceptance will occur at the destination. The contractor must adhere to strict packaging and marking standards, primarily Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must be commercial and sealed in suitable containers to prevent damage, with palletization following DLA requirement RP001. If the material is deemed hazardous per FED-STD-313, it must be packaged according to TQ requirement IP025 and labeled per the Hazard Communication Standard; otherwise, ASTM D3951 applies. Invoicing must be processed electronically through the Wide Area WorkFlow system. The award process includes a HUBZone price evaluation preference, and any offers utilizing additive manufacturing are ineligible for award.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

PERMETHRIN CREAM RINSE

Solicitation # SPE2DP-27-T-0202

This solicitation, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is a small business set-aside for the procurement of six units of Permethrin Cream Rinse (NSN 6505-01-256-4972). The required product is a 1% W/V Permethrin active ingredient supplied in a 2 fl oz plastic squeeze bottle and must include a comb. The item is FDA-regulated and has a total shelf life of 24 months, with a mandatory minimum of 21 months remaining upon receipt by the government. Delivery is required within five days after receipt of order (ADO) to a destination in Poland. The contract mandates strict adherence to medical and hazardous material standards, requiring marking in accordance with Medical Marking Standard No. 1 and packaging per MIL-STD-2073-1E. Suppliers must provide Safety Data Sheets (SDS) and Hazardous Communication Standard labels prior to award, with a copy of the SDS accompanying each shipment. Invoicing must be processed through the Wide Area WorkFlow (WAWF) system. Key regulatory clauses include the Buy American Act, DFARS cybersecurity reporting requirements, and the prohibition of additive manufacturing processes for the provided items. Inspection and acceptance will occur at the destination.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

HYDROGEN PEROXIDE TOPI

Solicitation # SPE2DP-27-T-0206

Solicitation SPE2DP-27-T-0206 is a request for quotations from the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of 50 bottles of Hydrogen Peroxide Topical Solution, USP. The product is an over-the-counter topical solution for external use containing 3% stabilized hydrogen peroxide, with each unit of issue consisting of a 473 milliliter bottle. Delivery is required within 20 days of award to a destination in Washington DC. The procurement is governed by NAICS code 325412 and requires compliance with the Buy American and Balance of Payments Program for quotes exceeding the micro-purchase threshold. The contractor must adhere to strict quality and safety standards, including FDA regulations and the DLA Master List of Technical and Quality Requirements. Packaging and marking must comply with MIL-STD-2073-1E, Medical Marking Standard No. 1, and Special Packaging Instructions MPPWN00001. Because the item is classified as hazardous material, the contractor must provide a current Material Safety Data Sheet (MSDS) and ensure all labeling and shipping comply with 49 CFR, ICAO, and IMDG regulations. Inspection and acceptance will occur at the destination per FAR 52.246-2. Invoicing and payment must be processed electronically through the Wide Area WorkFlow (WAWF) system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0207

Solicitation SPE2DP-27-T-0207 is a small business set-aside issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Simethicone Tablets, USP, 80 mg, chewable. The required product is an FDA-regulated drug provided in unit dose 100-count blister packs. Key technical specifications include a non-extendable shelf life of 36 months for Type I (Code Q) items. The contract requires delivery to the DC ARNG Med Det in Washington, DC, with a delivery window of 20 days after receipt of order and a required delivery date of November 2, 2026. The contractor must adhere to strict packaging and marking standards, specifically Medical Marking Standard No. 1, which supersedes MIL-STD-129, and packaging data per MIL-STD-2073-1E. Inspection and acceptance will occur at the destination. Administrative requirements include electronic invoicing via the Wide Area WorkFlow (WAWF) system and compliance with various FAR and DFARS clauses, including the Buy American Act and cybersecurity reporting under DFARS 252.204-7012. Quotations must be submitted via the DIBBS portal by November 4, 2026, and the submission of a Safety Data Sheet is mandatory for a responsibility determination.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-27-T-0208

Solicitation SPE2DP-27-T-0208, issued by DLA Troop Support Medical Supply Chain Pharm FSA, is a small business set-aside for the procurement of Loratadine 10 mg tablets (NSN 6505-01-524-9179). The requirement is for two bottles, with each bottle containing 500 tablets. The items are FDA-regulated and must be stored between 20° to 25° C and protected from excessive moisture. The product is classified as a Type I (Code Q) item with a non-extendable shelf life of 36 months. Delivery is required within 20 days after receipt of order, with terms set as FOB Destination and performance located at Camp Pendleton, California. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must be commercial, utilizing suitable sealed unit containers and exterior shipping containers in accordance with MIL-STD-2073-1E and special packaging instructions MPPWN00001. Inspection and acceptance will occur at the destination per FAR 52.246-2. Administrative requirements include the use of the Wide Area WorkFlow (WAWF) system for invoicing and payment. The solicitation incorporates various federal regulations, including the Buy American Act, DFARS requirements for safeguarding covered defense information, and prohibitions on certain telecommunications equipment. Quotations are due by November 4, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

BUPIVACAINE HYDROCHLOR

Solicitation # SPE2DP-27-T-0203

Solicitation SPE2DP-27-T-0203, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is a small business set-aside for the procurement of Bupivacaine Hydrochloride Injection, USP, 0.5%, 50 ML. The requirement consists of two units under NSN 6505001387347, with a non-extendable shelf life of 24 months. The product is FDA-regulated and must be stored between 20 to 25 degrees Celsius. Delivery is required within five days of award, with an original required delivery date of October 30, 2026, shipped FOB Destination to the US Army SSA in Powidz, Poland. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129 for medical materials. Packaging must be commercial, utilizing sealed unit containers and exterior shipping containers compliant with MIL-STD-2073-1E and DLA packaging requirements for palletization. Inspection and acceptance will occur at the destination per FAR 52.246-2. Administrative requirements include the use of the Wide Area WorkFlow system for electronic invoicing and payment. The solicitation incorporates various FAR and DFARS clauses regarding hazardous material identification, cybersecurity reporting, and domestic origin preferences under the Buy American Act.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 7 hours ago

DEADLINE

in 6 days

AI Contract Overview

Dextrose Injection 5% USP, 1000 mL, is a sterile, nonpyrogenic intravenous solution supplied in single-dose plastic bags, each containing 5 grams of anhydrous dextrose USP in water for injection USP, and is labeled as latex-free. The product is intended solely for intravenous administration and is packaged in units of 12 bags per package, with a strict shelf-life requirement of 30 months that is non-extendable. Storage must be maintained between 20°C and 25°C (68°F to 77°F), protected from freezing and excessive heat, in compliance with USP controlled room temperature standards. The item is subject to the latest DLA Master List of Technical and Quality Requirements, and packaging must adhere to MIL-STD-129 and the Medical Marking Standard No. 1, with no deviation permitted from DLA specifications even if ASTM D3951 is otherwise applicable. The product is not classified as hazardous under FED-STD-313, so commercial packaging standards are secondary to DLA requirements. Two separate delivery lines are specified under contract SPE2DP-26-T-4393, each for one package of 12 units, to be delivered FOB destination within five days of shipment, with no tolerance for quantity variance. Deliveries are directed to two U.S. Navy vessels, USS Jefferson City and USS Delaware, with shipping instructions requiring traceable transport and explicitly prohibiting parcel post. The contract specifies a required delivery date of August 3, 2026, and includes government-specific identifiers, logistics codes, and procurement data tied to the NSN 6505-01-330-6252, with full technical and quality compliance governed by DLA directives that supersede all other standards.

General Info

Dextrose 5% 1000mL IV bags, 12 per pack, latex-free, 30-month shelf life, stored at 20–25°C, delivered FOB destination to two Navy ships by August 3, 2026, per DLA specs.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

UNIT 100146 BOX 1, FPO, AP, 96669, USA

Set-Aside

NONE

Documents

RFQ SPE2DP-26-T-4393 Medical Supply Chain Pharma FSA

rfq

High

AI Contract Breakdown

Uniform Contract Format

Timeline

1 update

PhaseClosed

PostedJul 30

Solicitation

Notice updatedJul 30

The notice description changed.

Response DeadlineAug 5

Deadline has passed

Submission Closed

08/05/2026, 05:00:00 PM UTC

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Contacts1 person available

OfficeUSA

Organization / AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Office AddressUSA

Contacts

JAMES FOGGIE

contact@example.gov

+1 (555) 000-0000

Full Description

DEXTROSE INJECTION
DEXTROSE INJECTION 5%, USP, 1000 ML, 12S
RX ONLY.CONCENTRATION: 5%. TOTAL CONTENT: 1,000 ML STERILE AND
NONPYROGENIC.INTENDED FOR INTRAVENOUS ADMINISTRATION.SUPPLIED IN
SINGLE-DOSE CONTAINERS (BAGS).ROUTE: INTRAVENOUS DOSE FORM: INTRAVENOUS
SOLUTION STRENGTH: 5 %. LATEX-FREE. EACH 1,000 ML CONTAINS HYDROUS
DEXTROSE USP 5 GRAMS AND WATER FOR INJECTION USP.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
THE UNIT OF ISSUE IS A PACKAGE CONTAINING 12 EACH (PLASTIC BAGS). STORE
AT 20° TO 25°C (68° TO 77°F) [SEE USP CONTROLLED ROOM TEMPERATURE].
PROTECT FROM FREEZING AND AVOID EXCESS HEAT.
INCLUDE ZX001 OBJECT TEXT ID ST
RS019: Shelf-life requirement RS001 for a TYPE I (CODE P) item with a shelf life of 30 months (non-extendable) applies to this item.
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
.
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
B. BRAUN MEDICAL INC 11171 P/N L5100 B. BRAUN MEDICAL INC 11171 P/N NDC00264-7510-00 ICU MEDICAL, INC. 1RNZ0 P/N NDC00990-7922-09
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017682478 0001 PG 1.000
SPE2DP-26-T-4393
SECTION B
PR: 7017682478 PRLI: 0001 CONT’D
NSN/MATERIAL:6505013306252
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
R21605
USS JEFFERSON CITY SSN 759
UNIT 100146 BOX 1
FPO AP 96669
US
VESSEL SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANSPORTATION SEE DLAD PROC
NOTE C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
R21605
USS JEFFERSON CITY SSN 759
DLA VENDORS: USE VSM FOR
US
RDD 777 SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANSPORTATION SEE DLAD PROC
NOTE C20 AND CONTRACT
M/F: (TCN) R2160561853252
RDD: 777
PROJ: JK5 TP 2
SUPP ADD: YNMH01 SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 05
DIC: A41 DIST: E9B ADV: 2A FC: M7
Need Ship Date:00/00/0000 Original Required Delivery Date:08/03/2026
SPE2DP-26-T-4393
SECTION B
PR: 7017682478 PRLI: 0001 CONT’D

DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0002 7017682435 0001 PG 1.000
NSN/MATERIAL:6505013306252
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT PKGING DATA-QUP:001 IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313, PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025. IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
V27153
USS DELAWARE (SSN 791)
COMMANDING OFFICER
UNIT 100339 BOX 1
SPE2DP-26-T-4393
SECTION B
PR: 7017682435 PRLI: 0001 CONT’D
FPO AE 09583
US
VESSEL SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANSPORTATION SEE DLAD PROC
NOTE C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
V27153
USS DELAWARE (SSN 791)
DLA VENDORS: USE VSM FOR
US
RDD 777 SHIPMENT. SHIP BY FASTEST TRACEABLE MEANS. DO NOT USE PARCEL POST.
M/F: (TCN) V2715362033075
RDD: 777
PROJ: JP5 TP 1
SUPP ADD: YNMH01 SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 02
DIC: A4A DIST: E9B ADV: 2A FC: CC
Need Ship Date:00/00/0000 Original Required Delivery Date:08/03/2026
SPE2DP-26-T-4393 NSN/Part Number: 6505-01-330-6252 Quantity: 1 PG Purchase Request: 7017682478QTY: 1 Delivery: 5 days ADO